Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars
Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the efficacy and safety of the combination of intralesional
triamcinolone (at doses of 4mg / cm2 at intervals of 4 weeks) and topical pirfenidone 8%
(every 8 hours continuously) compared with their isolated application, in the treatment of
keloid scars in adults. The duration of this three-arm clinical trial will be 12 months, a
6-month period for treatment and a follow-up of 6 months to assess recurrences. The estimated
number of persons to be recruited and randomized for the study is 102.